NCT06165237View on ClinicalTrials.gov

"A Study to Evaluate the Drug-drug Interaction and Safety Between BR6001-1 and BR6001-2"

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 30, 2023

Primary Completion Date

May 9, 2023

Study Completion Date

May 9, 2023

Conditions
Gastric or Duodenal Ulcer
Interventions
DRUG

BR6001-1

One tablet administered alone, Once a day

DRUG

BR6001-2

One tablet administered alone, Once a day

Trial Locations (1)

Unknown

ChungBuk National University Hospital, Jungbuk

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY